Browsing: ad treatment

Dermatologist Dr Andrew Pink shares practical clinical insights on managing patients receiving nemolizumab for atopic dermatitis, including treatment expectations, adverse event monitoring, and counselling strategies in routine practice.

Dermatologist Dr Andrew Pink discusses the clinical profile of nemolizumab in atopic dermatitis, including its rapid effect on itch, improvements in sleep, and practical considerations when selecting therapy for patients with severe pruritus.

In this expert interview series, dermatologist Dr Andrew Pink explores the biological drivers of itch in atopic dermatitis and explains why addressing itch can significantly improve patients’ daily functioning and quality of life.